XM bietet keine Dienstleistungen für Personen mit Wohnsitz in den Vereinigten Staaten von Amerika an.

XM bietet keine Dienstleistungen für Personen mit Wohnsitz in den Vereinigten Staaten von Amerika an.
S
S

Symrise

Nachrichten

Reuters - vor 2 Wochen

Symrise slips, analysts points to lack of beat, guidance hike

BUZZ-Symrise slips, analysts points to lack of beat, guidance hike ** Shares in Symrise SY1G.DE slip around 2% after it posted in-line H1 results and confirmed its guidance, with analysts noting that investors were likely expecting more ** "We believe the market was looking rather for a slight beat to the consensus," Konstantin Wiechert at Baader H
G
S
G
Reuters - vor 2 Wochen

Symrise's half-year sales rise on fragrance business growth

UPDATE 2-Symrise's half-year sales rise on fragrance business growth H1 sales rise 6.3% year-on-year to 2.57 billion euros H1 EBITDA rises 11.5% to 529.8 million euros Sees 2024 organic growth at upper end of 5-7% guidance Adds CFO quote in paragraphs 5-6, share reaction in paragraph 8, analyst comments paragraph 9, division detail paragraph 11 By Antonis Pothitos Aug 1 (Reuters) - German flavour and fragrance maker Symrise SY1G.DE posted a 6.3% rise in its half-year sales on Thursday, in line w
G
K
L
S
Reuters - vor 2 Wochen

Symrise H1 Sales Increase By 6.3%

BRIEF-Symrise H1 Sales Increase By 6.3% Aug 1 (Reuters) - SYMRISE AG SY1G.DE : H1 GROUP SALES INCREASE BY 6.3 % TO EUR 2,565 MILLION; ORGANIC GROWTH OF 11.5 % IN LONG TERM, COMPANY AIMS TO INCREASE ITS SALES TO EUR 7.5 TO 8.0 BILLION BY 2028 IN LONG TERM EBITDA MARGIN SHOULD REMAIN WITHIN A TARGET CORRIDOR OF 20 TO 23 % Source text for Eikon: ID:nE
S
Reuters - vor 2 Wochen

Symrise posts 6% rise in half-year sales, meeting expectations

Symrise posts 6% rise in half-year sales, meeting expectations Aug 1 (Reuters) - German flavour and fragrance maker Symrise SY1G.DE posted a 6.3% rise in its half-year sales on Thursday, in line with estimates, driven by growth in both of its business areas. Symrise's revenue rose to 2.57 billion euros ($2.78 billion)in the January-June period from 2.41 billion a year earlier.
S
Reuters - vor 2 Wochen

Dsm-firmenich shares jump after core earnings forecast hike

UPDATE 2-Dsm-firmenich shares jump after core earnings forecast hike Adds CEO quote from analyst call in paragraphs 6-8, share move in paragraph 2 By Dimitri Rhodes and Anna Peverieri July 30 (Reuters) - Dutch chemicals maker dsm-firmenich DSFIR.AS raised its core earnings forecast for 2024 on Tuesday, banking on savings from the restructuring of its vitamin business and continued integration of DSM and Firmenich's legacy businesses.
G
S
N
Reuters - vor 2 Wochen

Dsm-firmenich raises forecast on vitamin business

Dsm-firmenich raises forecast on vitamin business July 30 (Reuters) - Dutch chemicals maker dsm-firmenich DSFIR.AS raised its annual core earnings forecast on Tuesday, helped by the vitamin transformation programme and improving business conditions. The company now sees adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) of around 2 billion euros ($2.16 billion) in 2024, up from the 1.9 billion euros previously forecast.
G
S
Reuters - vor 3 Wochen

Germany corporate earnings week ahead

DIARY-Germany corporate earnings week ahead July 26 (Reuters) - Diary of Germany (.GDAXI) corporate earnings for the week ahead GERMANY EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 30-Jul-2024 NTS 1COV.DE Covestro AG Half Year 2024 Covestro AG Earnings Release 30-Jul-2024 BMO HEIG.DE Heidelberg Materials AG Half Year 2024 Heidelberg Materials AG Earnings Release 30-Jul-2024 04:30 AIR.PA Airbus SE Half Year 2024 Airbus SE Earnings Release 31-Jul-2024 AMC QGEN.N Qiagen NV Q2 20
A
A
B
F
M
P
S
S
V
V
Q
G
Reuters - vor 1 Monat

JPM sees a 'more balanced' H1 for European Staples

BUZZ-JPM sees a 'more balanced' H1 for European Staples ** J.P.Morgan expects a "more balanced" H1 for European staples ** Says risk of challenging demand environment and growth threat from weakening pricing and worse forex market are partially offset by better margin outcome and continued volumes improvement ** Adds H1 may also highlight risks in the U.S.
B
D
D
H
J
S
A
P
Reuters - vor 2 Monaten

GS sees uneven recovery for European chemicals; ups Clariant, cuts Akzo

BUZZ-GS sees uneven recovery for European chemicals; ups Clariant, cuts Akzo ** Goldman Sachs favours consumer ingredient and gasses cos over diversified chemicals and paint makers based on pricing power, as the European chemicals sector faces an uneven recovery ** GS notes Europe's STOXX chemicals sub-index .SX4P is up 13% from its October 2023 tr
A
B
C
C
G
L
S
U
A
A
Reuters - vor 2 Monaten

Bechtle AG, Centrica, Clariant AG

EUROPE RESEARCH ROUNDUP-Bechtle AG, Centrica, Clariant AG July 1 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bechtle AG, Centrica and Clariant AG, on Monday. HIGHLIGHTS * Akzo Nobel NV AKZO.AS : Goldman Sachs cuts to sell from neutral * Bechtle AG BC8G.DE : Exane BNP Paribas cuts to underperform from neutral * Centrica CNA.L : Berenberg raises to buy from hold * Clariant AG CLN.S : Goldman Sachs raises to buy from neutral * Fin
A
A
A
A
B
B
B
C
C
C
D
D
H
H
P
S
S
A
A
F
J
Reuters - vor 2 Monaten

EU fines IFF for obstructing investigation of suspected fragrance cartel

EU fines IFF for obstructing investigation of suspected fragrance cartel BRUSSELS, June 24 (Reuters) - The European Commission said on Monday it had fined U.S. company International Flavors & Fragrances IFF.N (IFF) and its French affiliate 15.9 million euros ($17.05 million) for obstructing an inspection in an ongoing investigation of a suspected cartel in the supply of fragrances and fragrance ingredients.
G
S
I
Reuters - vor 2 Monaten

Givaudan, National Grid, Schneider Electric

EUROPE RESEARCH ROUNDUP-Givaudan, National Grid, Schneider Electric June 18 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Givaudan, National Grid and Schneider Electric, on Tuesday. HIGHLIGHTS * Crest Nicholson Holdings Plc CRST.L : RBC raises target price to 250p from 175p * Givaudan SA GIVN.S : JP Morgan raises target price to CHF 4,200 from CHF 3,800 * National Grid NG.L : Barclays cuts target price to 1120p from 1365p * Schne
A
B
C
C
E
G
G
H
H
H
I
I
L
L
N
P
S
S
S
H
A
A
N
S
S
W
Reuters - vor 2 Monaten

JPM puts Symrise on positive catalyst watch ahead of Q2

BUZZ-JPM puts Symrise on positive catalyst watch ahead of Q2 ** J.P.Morgan places Symrise SY1G.DE on positive catalyst watch into the German flavour and fragrance maker's Q2 results , expecting revenue growth at its Scent & Care division and good momentum behind margin rebuild ** Symrise's stock is up 1.4% in early Frankfurt trade ** JPM notes Symr
G
J
S
Reuters - vor 2 Monaten

Adidas AG, Crest Nicholson Holdings, Standard Chartered

EUROPE RESEARCH ROUNDUP-Adidas AG, Crest Nicholson Holdings, Standard Chartered June 17 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adidas AG, Crest Nicholson Holdings and Standard Chartered, on Monday. HIGHLIGHTS * Adidas AG ADSGn.DE : JP Morgan raises target price to EUR 250 from EUR 240 * Bellway Plc BWY.L : JP Morgan raises target price to 2,790p from 2,780p * Crest Nicholson Holdings Plc CRST.L : Peel Hunt raises target pr
A
A
B
B
B
C
C
C
E
E
G
H
J
L
O
P
S
S
S
U
A
A
F
U
Reuters - vor 2 Monaten

AB Dynamics, Etteplan, Wise

EUROPE RESEARCH ROUNDUP-AB Dynamics, Etteplan, Wise June 14 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including AB Dynamics, Etteplan and Wise, on Friday. HIGHLIGHTS * AB Dynamics Plc ABDP.L : Berenberg re-initiates coverage With Buy rating; PT 2,620p * Crest Nicholson CRST.L : Barclays cuts target price to 230p from 258p * Etteplan Oyj ETTE.HE : Evli Research raises to buy from hold * Halma HLMA.L : Barclays raises target price to 284
B
C
E
H
H
J
L
O
O
P
R
S
S
T
U
V
V
Z
H
A
R
Reuters - vor 2 Monaten

Dsm-firmenich sees boost as weight-loss drugs spur healthier choices

UPDATE 1-Dsm-firmenich sees boost as weight-loss drugs spur healthier choices Weight-loss drugs seen boosting demand for dietary supplements Preventive healthcare could raise interest in new ingredients Updates paragraph 12 to make it clear company is reviewing options including sale or IPO for Animal Nutrition division By Dimitri Rhodes and Matteo Allievi June 10 (Reuters) - The soaring popularity of weight-loss drugs are likely to spur demand for dietary supplements and healthier food formulat
G
K
L
S
Reuters - vor 2 Monaten

Dsm-firmenich sees boost as weight-loss drugs spur healthier choices

Dsm-firmenich sees boost as weight-loss drugs spur healthier choices Weight-loss drugs seen boosting demand for dietary supplements Preventive healthcare could raise interest in new ingredients By Dimitri Rhodes and Matteo Allievi June 10 (Reuters) - The soaring popularity of weight-loss drugs are likely to spur demand for dietary supplements and healthier food formulations, creating growth opportunities for dsm-firmenich, the CEO of the flavours to nutrition company told Reuters.
G
K
L
S
Reuters - vor 3 Monaten

DB sees Symrise 'earnings momentum turning a corner,' ups to 'buy'

BUZZ-DB sees Symrise 'earnings momentum turning a corner,' ups to 'buy' ** Deutsche Bank raises German flavour and fragrance maker Symrise SY1G.DE to "buy" from "hold," citing improved earnings momentum ** DB flags positive volume leverage and costs cuts, half of which kick in in H1 ** Although the company saw modest price pressure during Q1, it do
S
Reuters - vor 3 Monaten

European shares decline as cautious Fed commentary weighs

UPDATE 2-European shares decline as cautious Fed commentary weighs For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window German wholesale prices fall 1.8% in April STOXX 600 down 0.6% Updated at 1600 GMT By Shashwat Chauhan and Khushi Singh May 28 (Reuters) - European shares f ell in broad-based declines on Tuesday in the lead-up to crucial inflation prints around the world this week, while cautious commentary from Federal Reserve officials fu
D
J
O
S
F
E
F
U
G
Reuters - vor 3 Monaten

Argenx, Hermes, National Grid

EUROPE RESEARCH ROUNDUP- Argenx, Hermes, National Grid May 28 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Argenx, Hermes and National Grid, on Tuesday. HIGHLIGHTS * Argenx ARGX.BR : Barclays raises target price to EUR 375 from EUR 360 * Endomines Finland Oyj PAMPALO.HE : Evli Research raises to hold from sell * Hermes HRMS.PA : Bernstein raises to outperform from market perform * National Grid Plc NG.L : RBC cuts target price t
A
A
B
B
B
E
G
H
I
I
J
L
M
R
R
S
S
S
S
S
U
A
N
S

Konditionen

Beliebte Finanzwerte

Rechtlicher Hinweis: Die Unternehmen der XM Group bieten Dienstleistungen ausschließlich zur Ausführung an sowie Zugang zu unserer Online-Handelsplattform. Durch diese können Personen die verfügbaren Inhalte auf oder über die Internetseite betrachten und/oder nutzen. Eine Änderung oder Erweiterung dieser Regelung ist nicht vorgesehen und findet nicht statt. Der Zugang wird stets geregelt durch folgende Vorschriften: (i) Allgemeine Geschäftsbedingungen; (ii) Risikowarnungen und (iii) Vollständiger rechtlicher Hinweis. Die bereitgestellten Inhalte sind somit lediglich als allgemeine Informationen zu verstehen. Bitte beachten Sie, dass die Inhalte auf unserer Online-Handelsplattform keine Aufforderung und kein Angebot zum Abschluss von Transaktionen auf den Finanzmärkten darstellen. Der Handel auf Finanzmärkten birgt ein hohes Risiko für Ihr eingesetztes Kapital.

Sämtliche Materialien, die auf unserer Online-Handelsplattform veröffentlicht sind, dienen ausschließlich dem Zweck der Weiterbildung und Information. Die Materialien beinhalten keine Beratung und Empfehlung im Hinblick auf Finanzen, Anlagesteuer oder Handel und sollten nicht als eine dahingehende Beratung und Empfehlung aufgefasst werden. Zudem enthalten die Materialien keine Aufzeichnungen unserer Handelspreise sowie kein Angebot und keine Aufforderung für jegliche Transaktionen mit Finanzinstrumenten oder unverlangte Werbemaßnahmen für Sie zum Thema Finanzen. Die Materialien sollten auch nicht dahingehend aufgefasst werden.

Alle Inhalte von Dritten und die von XM bereitgestellten Inhalte sowie die auf dieser Internetseite zur Verfügung gestellten Meinungen, Nachrichten, Forschungsergebnisse, Analysen, Kurse, sonstigen Informationen oder Links zu Seiten von Dritten werden ohne Gewähr bereitgestellt. Sie sind als allgemeine Kommentare zum Marktgeschehen zu verstehen und stellen keine Anlageberatung dar. Soweit ein Inhalt als Anlageforschung aufgefasst wird, müssen Sie beachten und akzeptieren, dass der Inhalt nicht in Übereinstimmung mit gesetzlichen Bestimmungen zur Förderung der Unabhängigkeit der Anlageforschung erstellt wurde. Somit ist der Inhalt als Werbemitteilung unter Beachtung der geltenden Gesetze und Vorschriften anzusehen. Bitte stellen Sie sicher, dass Sie unseren Hinweis auf die nicht unabhängige Anlageforschung und die Risikowarnung im Hinblick auf die vorstehenden Informationen gelesen und zur Kenntnis genommen haben, die Sie hier finden.

Risikowarnung: Es bestehen Risiken für Ihr eingesetztes Kapital. Gehebelte Produkte sind nicht für alle Anleger geeignet. Bitte beachten Sie unseren Risikohinweis.